TABLE 2.

Percentages of CD16⁻ T lymphocytes that are Gag- specific CD8⁺ or CD4⁺ cells in vaccinated animals^a

Vaccine (route)		Animal	% CD16− T cells that wereb:
Priming	Booster		CD4+	CD8+
Ad5	Ad5	11017	0.17	1.84
		11361	0.10	0.25
		14232	0.06	0.52
Ad5 (s.c.)	Ad5 (s.c.)	10041	0.10	0.14
		11039	0.09	0.73
		11096	0.06	0.18
None	Ad5	8698	0.01	0.51
		10875	0.02	0.06
		10432	0.04	0.20
DNA	Ad5	9895	0.07	0.03
		11251	0.05	0.02
		14811	0.05	0.38
DNA-alum	Ad5	8988	0.07	0.56
DNA-CRL1005	Ad5	11876	0.26	0.67
DNA-alum	MVA	9783	0.35	0.02
DNA-CRL1005	MVA	10544	0.23	0.04
		11247	0.02	0.01

^aData are based on IFN-γ ICS analyses of PBMCs collected at week 28 (4 weeks postbooster). s.c., subcutaneously; alum, aluminum phosphatase.

^bMock-subtracted values.